Patents by Inventor Ralph Meyer
Ralph Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240009582Abstract: A gyroscope includes a frame that surrounds a wheel and a weight that is connected to the wheel. A pair of wheel axles extend from the wheel and connect the wheel to the frame so that the wheel may rotate with respect to the frame. The frame also includes end pivot frames that provide a mounting point for end pivots to be removably attached to the frame. A zip cord may interact with a starting gear on one of the wheel axles to cause rotation of the wheel with respect to the frame.Type: ApplicationFiled: July 11, 2023Publication date: January 11, 2024Applicant: Tedco Inc.Inventors: Jonathan Patrick Meyer, Ralph Meyer
-
Patent number: 10238453Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.Type: GrantFiled: October 15, 2015Date of Patent: March 26, 2019Assignee: AngioDynamics, Inc.Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
-
Publication number: 20160030113Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.Type: ApplicationFiled: October 15, 2015Publication date: February 4, 2016Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, JR., Joe D. Brown
-
Publication number: 20150025512Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.Type: ApplicationFiled: September 12, 2014Publication date: January 22, 2015Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
-
Patent number: 8864755Abstract: An endovascular treatment method for causing closure of a blood vessel is provided. The method includes inserting into a blood vessel an optical fiber having a core through which a laser light travels and a spacer sleeve arranged around a distal portion of the core. A distal end of the core defines an enlarged light emitting face, which advantageously provides substantially lower power density while providing the same amount of total energy during a treatment session. After the insertion, laser light is applied through the light emitting face while the inserted optical fiber and spacer sleeve are longitudinally moved. The spacer sleeve positions the light emitting face away from an inner wall of the blood vessel and application of the laser light causes closure of the blood vessel.Type: GrantFiled: August 3, 2012Date of Patent: October 21, 2014Assignee: AngioDynamics, Inc.Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
-
Patent number: 8864754Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.Type: GrantFiled: April 9, 2008Date of Patent: October 21, 2014Assignee: AngioDynamics, Inc.Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
-
Publication number: 20140186311Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.Type: ApplicationFiled: January 21, 2014Publication date: July 3, 2014Applicant: HEART BIOSYSTEMS GMBHInventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
-
Patent number: 8568972Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.Type: GrantFiled: July 6, 2009Date of Patent: October 29, 2013Assignee: Medicyte GmbHInventors: Jan-Heiner Kuepper, Reinhard Kandolf, Ralph Meyer
-
Publication number: 20130035287Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.Type: ApplicationFiled: June 22, 2012Publication date: February 7, 2013Applicant: HEART BIOSYSTEMS GMBHInventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
-
Publication number: 20120316546Abstract: An endovascular treatment method for causing closure of a blood vessel is provided. The method includes inserting into a blood vessel an optical fiber having a core through which a laser light travels and a spacer sleeve arranged around a distal portion of the core. A distal end of the core defines an enlarged light emitting face, which advantageously provides substantially lower power density while providing the same amount of total energy during a treatment session. After the insertion, laser light is applied through the light emitting face while the inserted optical fiber and spacer sleeve are longitudinally moved. The spacer sleeve positions the light emitting face away from an inner wall of the blood vessel and application of the laser light causes closure of the blood vessel.Type: ApplicationFiled: August 3, 2012Publication date: December 13, 2012Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, JR., Joe D. Brown
-
Publication number: 20090291429Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.Type: ApplicationFiled: July 6, 2009Publication date: November 26, 2009Inventors: Jan-Heiner KUEPPER, Reinhard KANDOLF, Ralph MEYER
-
Publication number: 20090131924Abstract: An endovenous thermal treatment device in which a thermal energy delivery device can be inserted into a blood vessel without the use of a treatment sheath is provided. The treatment device includes a carrier wire having a flexible distal section and a longitudinal energy delivery device having a distal energy emitting section. A coupler couples the carrier wire and the energy delivery device so that they are inserted together into a blood vessel.Type: ApplicationFiled: November 14, 2008Publication date: May 21, 2009Inventors: Ralph A. Meyer, William M. Appling
-
Publication number: 20080287939Abstract: An elongated thermal energy delivery device for use in endovenous thermal treatment of blood vessel is provided. The energy device includes a flexible guide tip attached to its distal portion which provides for direct tracking and advancement of the energy device through the vein without the use of a treatment sheath. Also provided is a method of using the thermal energy delivery device with flexible guide tip. The method eliminates the need for a treatment sheath and accessory procedural components and the procedural steps associated with these components.Type: ApplicationFiled: June 30, 2008Publication date: November 20, 2008Inventors: William M. Appling, Ralph A. MEYER, Leonard G. Schaefer
-
Publication number: 20080221058Abstract: The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.Type: ApplicationFiled: February 13, 2008Publication date: September 11, 2008Inventors: Jan-Heinerr Kupper, Ralph Meyer, Mirella Meyer-Ficca, Reinhard Kandolf
-
Publication number: 20080188843Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.Type: ApplicationFiled: April 9, 2008Publication date: August 7, 2008Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Joe D. Brown
-
Patent number: 7351697Abstract: The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.Type: GrantFiled: July 21, 2005Date of Patent: April 1, 2008Inventors: Jan-Heinerr Küpper, Ralph Meyer, Mirella Meyer-Ficca, Reinhard Kandolf
-
Publication number: 20070237754Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.Type: ApplicationFiled: May 21, 2007Publication date: October 11, 2007Inventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
-
Publication number: 20070025971Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.Type: ApplicationFiled: July 27, 2006Publication date: February 1, 2007Inventors: Jan-Heiner Kuepper, Reinhard Kandolf, Ralph Meyer
-
Patent number: D976982Type: GrantFiled: May 20, 2019Date of Patent: January 31, 2023Assignee: NICO CORPORATIONInventor: Ralph A. Meyer
-
Patent number: D1035735Type: GrantFiled: December 13, 2022Date of Patent: July 16, 2024Assignee: NICO CORPORATIONInventor: Ralph A. Meyer